The "FISH - Multiple Myeloma with Positive Selection of CD138 Cells Test" is a sophisticated diagnostic procedure offered by DNA Labs UAE, designed specifically for the detection and analysis of multiple myeloma, a type of cancer that affects plasma cells in the bone marrow. This test employs Fluorescence In Situ Hybridization (FISH), a powerful genetic technique, combined with the positive selection of CD138+ cells, which are a hallmark of multiple myeloma. By isolating these cells, the test enhances the accuracy of detecting chromosomal abnormalities associated with the disease.
The cost of the test is 3040 AED, reflecting the advanced technology and specialized expertise required to perform this analysis. The process involves collecting a bone marrow sample from the patient, followed by the isolation of CD138+ cells. These cells are then analyzed using FISH to identify specific genetic changes that can guide treatment decisions and prognostic assessments.
DNA Labs UAE, known for its commitment to precision medicine, provides this test as part of its comprehensive range of diagnostic services aimed at facilitating early detection and personalized treatment strategies for cancer patients.
The "Neuronal Paraneoplastic Autoantibodies Profile Ultra Test" is a specialized diagnostic procedure available at DNA Labs UAE, designed to detect the presence of specific autoantibodies associated with paraneoplastic neurological syndromes (PNS). These syndromes are rare disorders triggered by an immune response to certain cancers, where the immune system mistakenly attacks parts of the nervous system, leading to neurological symptoms. The test aims to identify a range of autoantibodies that target neuronal tissues, providing crucial information for the diagnosis and management of PNS. This can be particularly important for identifying underlying malignancies at an early stage, allowing for timely treatment interventions. The cost of the test is 3040 AED, reflecting the comprehensive nature of the analysis and the sophisticated technology used to achieve accurate results. Conducted at DNA Labs UAE, a facility known for its advanced diagnostic capabilities, this test represents a critical tool in the early detection and management of paraneoplastic neurological syndromes, offering hope for affected patients through targeted therapy and interventions.
The Transplant Infectious Screening Profile Test is a critical medical examination designed to ensure the safety and compatibility of organ transplants. Conducted at DNA Labs UAE, this comprehensive screening test is priced at 3040 AED. It aims to detect any potential infectious agents in the donor's body that could pose a risk to the recipient's health post-transplantation. By evaluating a range of infectious diseases, including viruses, bacteria, and other pathogens, this screening helps in minimizing the risk of infection transmission during the transplant process. The test is an essential step in the pre-transplant evaluation, ensuring that both the donor and recipient are safeguarded against potential infectious complications, thereby enhancing the overall success rate of organ transplantation procedures.
The Purkinje Cell Cytoplasmic Antibody Type Tr (PCA-Tr) DNER Test is a specialized diagnostic procedure aimed at detecting the presence of specific autoantibodies targeting the Delta/Notch-like epidermal growth factor-related receptor (DNER) on Purkinje cells. These autoantibodies are associated with autoimmune neurological disorders, particularly Paraneoplastic Cerebellar Degeneration (PCD), which can occur in the context of underlying malignancies. The test is crucial for early diagnosis and management of such conditions, guiding appropriate treatment strategies to mitigate neurological symptoms and addressing the primary cancer when present.
Conducted at DNA Labs UAE, a state-of-the-art facility known for its advanced diagnostic capabilities, the PCA-Tr DNER Test is priced at 3040 AED. The lab ensures accurate and reliable results, leveraging cutting-edge technology and a team of expert technicians and pathologists. By opting for this test at DNA Labs UAE, patients and healthcare providers can expect a seamless diagnostic experience, contributing to timely and effective disease management.
The Myositis Profile Extended IgG 16 Antigens Test is a specialized diagnostic assessment designed to detect and measure specific antibodies associated with myositis, an inflammatory condition affecting the muscles. This comprehensive test targets 16 distinct antigens that are commonly associated with different forms of myositis, including polymyositis, dermatomyositis, and other related autoimmune conditions. By identifying the presence and concentration of these antibodies, healthcare providers can gain valuable insights into the specific type of myositis a patient may have, guiding treatment decisions and management strategies.
Performed at DNA Labs UAE, a reputable facility known for its advanced diagnostic services, this test ensures accuracy and reliability in results. The cost of the Myositis Profile Extended IgG 16 Antigens Test is 3020 AED, reflecting the intricate nature of the analysis and the sophisticated technology employed. Patients seeking this test can expect a thorough diagnostic experience, with results that provide a clearer understanding of their condition and a path forward for treatment.
The "Cancer Gene Any 3 Markers NGS Test" offered by DNA Labs UAE is a cutting-edge diagnostic tool designed to identify specific genetic markers associated with cancer. Utilizing Next-Generation Sequencing (NGS) technology, this test can analyze three specific genes chosen by the patient or healthcare provider to look for mutations that may indicate a higher risk of developing cancer or to understand the genetic makeup of a cancer that has already been diagnosed. This information is crucial for personalized treatment planning, as it can help in selecting targeted therapies that are more likely to be effective based on the genetic profile of the cancer.
The test is priced at 3230 AED, reflecting the advanced technology and expertise required to perform the analysis. Conducted in the state-of-the-art facilities of DNA Labs UAE, the process involves collecting a sample of blood or tissue, which is then subjected to comprehensive genomic sequencing. The results provide detailed insights into the genetic abnormalities present, aiding in early detection, prognosis, and the customization of treatment strategies.
This test represents a significant advancement in the field of oncology, offering hope for more effective management of cancer through precision medicine. By identifying specific genetic markers, patients and doctors can make informed decisions about the most appropriate and potentially effective treatment options, improving outcomes and quality of life for those affected by cancer.
The "LPL Expert Panel 1 Test" offered at DNA Labs UAE is a specialized genetic test designed to assess variations in the LPL gene, which plays a crucial role in lipid metabolism. This panel is particularly valuable for individuals seeking to understand their genetic predisposition to lipid disorders, including hyperlipidemia and pancreatitis, which are linked to the function of the lipoprotein lipase enzyme. The test, priced at 3160 AED, involves a detailed analysis of the LPL gene to identify mutations that may impact lipid levels in the blood, providing essential information for personalized medical guidance and lifestyle adjustments. Conducted in the advanced facilities of DNA Labs UAE, the test adheres to high standards of accuracy and reliability, making it a trusted choice for those looking to gain insights into their genetic health profile concerning lipid metabolism.
Minimal Residual Disease (MRD) analysis is a critical diagnostic tool used in the management of T-cell Acute Lymphoblastic Leukemia (T-ALL), a type of cancer that affects the white blood cells. This advanced testing method is designed to detect the smallest traces of cancer cells that remain in the patient's body after treatment, which are often undetectable by traditional methods. The ability to accurately measure MRD helps oncologists assess the effectiveness of treatment, adjust therapy protocols accordingly, and predict patient outcomes with greater precision.
The MRD Analysis for T-ALL Test offered at DNA Labs UAE utilizes cutting-edge molecular and cytometric technologies to provide a highly sensitive assessment of disease status. This enables healthcare providers to make informed decisions regarding the need for additional treatment or intervention, thus optimizing patient care strategies and improving the chances of achieving long-term remission.
The cost of the MRD Analysis for T-ALL Test at DNA Labs UAE is 3160 AED. This investment in health allows patients and their families to access state-of-the-art diagnostic capabilities, contributing significantly to the personalized management of T-ALL and enhancing the likelihood of successful treatment outcomes.
The PCNA (Proliferating Cell Nuclear Antigen) Antibody Test is a diagnostic tool utilized to detect and measure the presence of PCNA antibodies in the blood. PCNA is a protein found in the nucleus of cells and plays a crucial role in the process of DNA replication and repair, making it an important marker for cell proliferation. This test is particularly useful in the study and monitoring of cancerous growths and other conditions that involve rapid cell proliferation.
Administered at DNA Labs UAE, a leading facility in medical diagnostics, the test provides valuable insights for healthcare professionals in the management and treatment planning of various diseases. The cost of the PCNA Proliferating Cell Nuclear Antigen Antibody Test at DNA Labs UAE is set at 3160 AED. This investment allows for the accurate assessment of disease progression and response to treatment, contributing significantly to personalized medicine and patient care strategies.
The Acetylcholine Receptor (AChR) Modulating Antibody Test is a specialized diagnostic procedure aimed at detecting antibodies that may alter the function of acetylcholine receptors. These receptors are crucial for the transmission of signals between nerves and muscles, and their disruption can lead to a range of neuromuscular disorders, most notably Myasthenia Gravis. The presence of modulating antibodies can lead to the degradation and loss of acetylcholine receptors, thereby affecting muscle strength and causing symptoms such as muscle weakness and fatigue.
The test is particularly valuable for the diagnosis and management of Myasthenia Gravis, as it helps in understanding the severity of the condition and guiding treatment strategies. It involves taking a blood sample from the patient, which is then analyzed in a laboratory to detect the presence of these specific antibodies.
At DNA Labs UAE, this test is available for a cost of 3150 AED. DNA Labs UAE is equipped with state-of-the-art facilities and employs advanced testing methodologies to ensure accurate and reliable results. The test is conducted by a team of specialized medical professionals who are experienced in handling and analyzing samples for a wide range of conditions, including those related to neuromuscular transmission disorders. By opting for this test at DNA Labs UAE, patients can expect a thorough and precise evaluation of their condition, aiding in the effective management and treatment of symptoms related to acetylcholine receptor modulation.
